Malaria vaccine hits Phase III - The Scientist - Magazine of the Life Sciences

Supplements

Survey Series

The Scientist Daily

Science headlines delivered daily.
Register today.

Institutions

For Advertisers

Bookmark & Share

Del.icio.us

Digg

Facebook

Google

Twitter

Stumble it!

Yahoo!

Printer friendly version

Email to a friend

Close Window

News:

Malaria vaccine hits Phase III

Posted by Jef Akst

[Entry posted at 3rd November 2009 05:01 AM GMT]

Comment on this news story

The first-ever Phase III trial for a malaria vaccine has officially begun, with more than 5,000 African children already given the first round of malaria vaccine candidate RTS,S, researchers announced today (November 3) at a ...

For FREE access to this news story and more, you must register.


	The article you are attempting to read is only available to registered users of The Scientist. Registration is FREE and only takes a few seconds.

Create your MyScientist account and access all of The Scientist's free content, tools and life science email newsletters, including:

> The current month’s print issue

> Daily & Bi-weekly e-mail newsletters

> Newsblogs with breaking headlines

> The Scientist Community

> Exclusive web extras

> The Scientist Careers

Premium content from The Scientist Archive, a comprehensive resource of over 22 years of past life science coverage, is available only by subscription. Subscribe today and get unlimited access